SCN4A and hyperkalemic periodic paralysis: Mutations in the SCN4A have been linked to various neuromuscular disorders in humans, including myotonia (G1306E), hyperkalemic periodic paralysis (T704M), and myasthenic myopathy (R1454W) [32–34].